Placebo 40 mg

DRUG3 trials

Sponsors

Boehringer Ingelheim, Sumitomo Pharma America, Inc., Johns Hopkins University

Conditions

Coronary ArteriosclerosisFibroid TumorFibroid UterusFibromyomaHypertensionLeiomyomaLeiomyoma, UterinePharmacokinetics

Phase 1

A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

CompletedNCT00549666

Sumitomo Pharma America, Inc.Pharmacokinetics

Start: 2007-08-31End: 2007-12-31Updated: 2011-09-14

Phase 2

Effects of Simvastatin on Uterine Leiomyoma Size

RecruitingNCT03400826

Johns Hopkins UniversityFibroid Tumor, Fibroid Uterus, Fibromyoma +2

Start: 2018-08-20End: 2026-07-31Target: 60Updated: 2025-07-14

Phase 4

Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

CompletedNCT00274144

Boehringer IngelheimCoronary Arteriosclerosis, Hypertension

Start: 2001-12-31End: 2004-05-31Target: 42Updated: 2013-11-01